Skip to main content
. 2022 Feb 3;128(11):2278–2289. doi: 10.1017/S0007114522000423

Table 2.

Relative intakes (percentage of total energy intake) for each NOVA food group (dose–response analysis of tertiles) in association with breast cancer risk (Odds ratios and 95 % confidence intervals)

Unprocessed/minimally processed foods Culinary ingredients Processed foods Ultra-processed foods
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI
Overall (cases n 396; controls (n 396)
  Lowest tertile 1 1 1 1 1 1 1 1
  Middle tertile 1·02 0·73, 1·42 1·01 0·72, 1·43 0·90 0·65, 1·26 0·84 0·59, 1·19 0·83 0·59, 1·17 0·79 0·54, 1·14 1·28 0·91, 1·83 1·36 0·89, 2·10
  Highest tertile 0·50 0·34, 0·73 0·52 0·35, 0·78 0·53 0·36, 0·75 0·55 0·38, 1·32 0·53 0·37, 0·77 0·86 0·63, 1·15 0·47 0·31, 0·72 1·03 0·72, 1·45
  P-trend <0·001 0·001 <0·001 0·336 0·001 0·210 <0·001 0·149
Premenopausal (cases n 148; controls n 139)*
  Lowest tertile 1 1 1 1 1 1 1 1
  Middle tertile 0·72 0·42, 1·26 0·66 0·37, 1·18 1·00 0·58, 1·72 0·94 0·54, 1·65 0·68 0·39, 1·21 0·74 0·41, 1·32 1·14 0·64, 2·05 1·25 0·68, 2·25
  Highest tertile 0·56 0·31, 1·03 0·51 0·27, 0·95 0·74 0·41, 1·33 0·67 0·37, 1·24 0·43 0·23, 0·78 0·45 0·24, 1·56 0·63 0·32, 1·22 0·62 0·32, 1·22
 P-trend 0·062 0·035 0·311 0·212 0·192 0·445 0·171 0·168
Postmenopausal (cases n 248; controls n 257)*
  Lowest tertile 1 1 1 1 1 1 1 1
  Middle tertile 1·23 0·81, 1·86 1·26 0·83, 1·92 0·77 0·51, 1·18 0·72 0·46, 1·10 0·91 90·59, 1·38 0·90 0·59, 1·38 1·41 0·93, 2·12 1·44 0·95, 2·12
  Highest tertile 0·50 0·32, 0·78 0·55 0·35, 0·89 0·45 0·29, 1·10 0·46 0·29, 1·33 0·60 0·39, 1·23 0·65 0·42, 1·03 0·48 0·30, 0·75 0·89 0·62, 1·29
  P-trend 0·003 0·012 0·201 0·112 0·122 0·070 0·104 0·130
ER+ (cases n 298)
  Lowest tertile 1 1 1 1 1 1 1 1
  Middle tertile 0·86 0·32, 2·28 0·91 0·31, 2·71 0·78 0·29, 2·09 1·03 0·34, 3·13 2·13 0·78, 5·83 2·33 0·75, 7·26 3·69 1·31, 10·41 5·41 1·66, 7·91
  Highest tertile 0·52 0·21, 1·30 0·53 0·19, 1·48 0·64 0·30, 1·38 0·75 0·32, 1·73 0·71 0·32, 1·51 0·79 0·34, 1·82 1·01 0·42, 2·45 1·31 0·48, 3·57
  P-trend 0·165 0·226 0·260 0·505 0·369 0·581 0·974 0·586
PR+ (cases n 263)
  Lowest tertile 1 1 1 1 1 1 1 1
  Middle tertile 0·53 0·16, 1·71 0·52 0·14, 1·97 1·38 0·45, 4·21 1·61 0·42, 0·62 1·27 0·42, 3·81 2·29 0·56, 0·93 4·43 1·29, 6·39 8·95 1·93, 41·45
  Highest tertile 0·30 0·90, 0·93 0·23 0·06, 0·86 0·71 0·31, 1·65 0·74 0·28, 1·94 0·48 0·19, 1·19 0·51 0·17, 1·55 0·89 0·33, 2·44 1·11 0·34, 3·58
  P-trend 0·037 0·029 0·433 0·551 0·114 0·237 0·823 0·854
BMI < 30 kg/m2 (cases = 165; controls n 161)
  Lowest tertile 1 1 1 1 1 1 1 1
  Middle tertile 1·15 0·68, 1·93 1·07 0·61, 1·87 1·31 0·77, 2·23 1·32 0·77, 2·27 1·08 0·64, 1·82 1·04 0·60, 1·81 1·25 0·75, 2·01 1·22 0·67, 2·25
  Highest tertile 0·50 0·28, 0·88 0·47 0·26, 0·85 0·61 0·35, 1·05 0·58 0·33, 1·01 1·21 0·84, 1·73 0·50 0·29, 1·23 1·18 0·82, 1·71 1·01 0·59, 1·52
  P-trend 0·117 0·014 0·074 0·056 0·310 0·872 0·354 0·516
Obesity (cases n 231; controls n 235)*,
  Lowest tertile 1 1 1 1 1 1 1 1
  Middle tertile 0·93 0·61, 1·43 0·89 0·57, 1·37 0·64 0·42, 0·98 0·61 0·39, 0·94 0·70 0·45, 1·08 0·70 0·45, 1·09 1·35 0·88, 2·08 1·3 0·84, 2·02
  Highest tertile 0·55 0·35, 0·89 0·57 0·35, 0·92 0·48 0·31, 1·04 0·51 0·32, 1·21 0·56 0·36, 1·09 0·59 0·37, 1·03 0·64 0·40, 1·05 0·67 0·41, 1·08
  P-trend 0·014 0·021 0·071 0·203 0·116 0·115 0·077 0·103

ER+, oestrogen receptor positive; PR+, progesterone receptor positive.

Model 1: crude output.

Model 2: adjusted for individual income per month, ethnicity, physical activity, waist circumference (not adjusted for waist circumference when stratified by obesity status) and menopausal status (not adjusted for menopause when stratified by menopausal status).

*

Unconditional logistic regression.

Obesity defined as BMI ≥ 30 kg/m2.